Kontoor Brands declares quarterly dividend, raises payout by 2%
Kontoor Brands, Inc. has declared a quarterly cash dividend of $0.54 per share, marking a 2% increase from previous payouts.
Greenland Energy Co Board Member Resigns Amid Changes
Greenland Energy Co announces the resignation of Roderick McIllree from its Board of Directors, effective immediately, signaling potential leadership shifts.
Supernus secures orphan-drug exclusivity for ONAPGO
Supernus Pharmaceuticals announces seven years of orphan-drug exclusivity for ONAPGO, enhancing its position in the pharmaceutical industry.
Capstone Holding Corp. implements 1-for-30 reverse stock split
Capstone Holding Corp. announces a reverse stock split of 1-for-30, effective October 19, 2026, impacting its common stock trading.
SLM Student Loan Trust 2006-5 Faces Failed Remarketing Event
SLM Student Loan Trust 2006-5 reports a failed remarketing of class A-6B and A-6C notes, impacting investor retention and market confidence.
RLI Corp. reports third-quarter results in analyst call
RLI Corp. discusses third-quarter financial results in an analyst call, highlighting performance in the fire, marine, and casualty insurance sector.
Home Federal Bancorp declares quarterly cash dividend
Home Federal Bancorp, Inc. of Louisiana declares a $0.15 quarterly cash dividend, payable on November 16, 2026, signaling stability in the savings institution sector.
CrossAmerica Partners LP Declares Q3 2026 Distribution
CrossAmerica Partners LP announces a quarterly distribution of $0.5250 per unit for Q3 2026, reflecting its commitment to steady returns for unitholders.
Minerals Technologies declares quarterly dividend of $0.13
Minerals Technologies Inc. announces a quarterly dividend of $0.13 per share, payable on December 3, 2026, to shareholders of record on November 5, 2026.
Medline Inc. to Discontinue All Medline Brand Beds
Medline Inc. announces a voluntary field action to remove all Medline Brand beds, affecting $60 million in sales and incurring up to $220 million in costs.
Allspring Global Dividend Opportunity Fund Changes Fiscal Year End
Allspring Global Dividend Opportunity Fund shifts its fiscal year end to December 31, aligning with calendar year-end practices for better reporting.
Plumas Bancorp Declares Quarterly Cash Dividend of $0.33
Plumas Bancorp announces a quarterly cash dividend of $0.33 per share, payable on November 17, 2026, reflecting its commitment to shareholder value.
Korro Bio announces preclinical results for KRRO-111
Korro Bio, Inc. reveals preclinical results for KRRO-111, a treatment for Alpha-1 Antitrypsin Deficiency, potentially impacting the pharmaceutical industry.
Structured Obligations Corp announces distribution to holders
Structured Obligations Corp Long Term Certs Series 2003-5 reports a distribution to certificate holders, highlighting ongoing activity in asset-backed securities.
Structured Obligations Corp announces distribution for 2026
Structured Obligations Corp Long Term Certs Series 2003-4 announces a distribution to holders of its Select Notes Trust LT 2003-4, totaling $168,696.63.
Biohaven receives FDA nod for Vyglxia resubmission review
Biohaven Ltd. announces FDA acceptance of its resubmission for Vyglxia, a drug for spinocerebellar ataxia, marking a crucial step in its development.
Structured Obligations Corp Announces Distribution to Holders
Structured Obligations Corp Select Notes Trust LT Series 2003-1 announces a distribution to certificate holders, reflecting ongoing activity in asset-backed securities.
MBX Biosciences appoints Peter Radovich as new director
MBX Biosciences has appointed Peter Radovich to its board of directors, signaling a strategic move in the pharmaceutical preparations sector.
Fractyl Health announces workforce reduction, leadership change
Fractyl Health, Inc. announces a 45% workforce reduction and the retirement of its President, Jay Caplan, as part of a strategic shift.
MIRA Pharmaceuticals Reports Positive Results for MIRA-55
MIRA Pharmaceuticals announces promising results from a preclinical study of MIRA-55, a potential pain relief drug, aiming for an IND submission in 2027.